http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9517200-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0278
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
filingDate 1994-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f512f60dd5a2da8f89bcaf8aa8d6f037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e52fc881e027e781932e4dcba9c3adde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0857abb54bfcc090944455dd0fda545b
publicationDate 1995-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9517200-A1
titleOfInvention METHODS FOR THE PRODUCTION AND USE OF ANTI-IDIOTYPIC ANTIBODIES USING HUMAN Ig EXPRESSING TRANSGENIC ANIMALS
abstract Methods for production of enriched populations of anti-idiotypic antibodies are provided. These antibodies are produced by immunizing transgenic non-human animals. The transgene utilized in these animals encodes and, in the animals, expresses an immunoglobulin protein which is idiotypically different from the immunizing immunoglobulin. The animals therefore produce virtually no antibodies against constant region determinants on the immunoglobulin expressed by the transgene. A preferred method will produce enriched populations of monoclonal anti-idiotypic antibodies utilizing hybridomas formed by fusion of splenocytes taken from the transgenic animals of the invention.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9321846-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2193145-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1917854-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014139198-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2193145-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010537983-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8969024-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008115180-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11230697-B2
priorityDate 1993-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4683295-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5034316-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129322018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399873
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134

Total number of triples: 48.